43 related articles for article (PubMed ID: 10914745)
1. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
[TBL] [Abstract][Full Text] [Related]
2. The kinetic origins of the restriction point in the mammalian cell cycle.
Aguda BD; Tang Y
Cell Prolif; 1999 Oct; 32(5):321-35. PubMed ID: 10619492
[TBL] [Abstract][Full Text] [Related]
3. CDK4/6 activity is required during G
McKenney C; Lendner Y; Guerrero Zuniga A; Sinha N; Veresko B; Aikin TJ; Regot S
Science; 2024 May; 384(6695):eadi2421. PubMed ID: 38696576
[TBL] [Abstract][Full Text] [Related]
4. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.
Kusaczuk M; Krętowski R; Bartoszewicz M; Cechowska-Pasko M
Tumour Biol; 2016 Jan; 37(1):931-42. PubMed ID: 26260271
[TBL] [Abstract][Full Text] [Related]
5. Phenylbutyrate inhibits growth of cervical carcinoma cells independent of HPV type and copy number.
Finzer P; Stöhr M; Seibert N; Rösl F
J Cancer Res Clin Oncol; 2003 Feb; 129(2):107-13. PubMed ID: 12669235
[TBL] [Abstract][Full Text] [Related]
6. Pathways governing G1/S transition and their response to DNA damage.
Bartek J; Lukas J
FEBS Lett; 2001 Feb; 490(3):117-22. PubMed ID: 11223026
[TBL] [Abstract][Full Text] [Related]
7. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
9. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
10. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
11. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
12. Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells.
Wang QM; Feinman R; Kashanchi F; Houghton JM; Studzinski GP; Harrison LE
Clin Cancer Res; 2000 Jul; 6(7):2951-8. PubMed ID: 10914745
[TBL] [Abstract][Full Text] [Related]
13. Induction of S phase by G1 regulatory factors.
Kato J
Front Biosci; 1999 Dec; 4():D787-92. PubMed ID: 10577389
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
